Skip to content
UK Neqas Cardiac Markers
  • Home
  • Scheme Information
  • Register to participate
  • Distribution Dates
  • News
  • Contact Us
UK Neqas Cardiac Markers
Science

Troponins Touted as ‘Ally’ in COVID-19 Triage

Posted April 18, 2020 Alan Reid

Troponins Touted as ‘Ally’ in COVID-19 Triage.

 

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047008

 

Post navigation

⟵COVID-19 Statement form UK NEQAS and UK NEQAS Cardiac Markers
HEART Editorial: High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action⟶

Recent Posts

  • The Innovation Agency (Academic Health Science Network for the North West Coast):Support available to implement updated NICE Diagnostics Guidance DG40: High Sensitivity troponin tests for the early rule out of NSTEMI
  • UK NEQAS Pan-disciplinary Educational Webinars 2020
  • NT-proBNP Commentary (Distribution 264)
  • HEART Editorial: High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action
  • Troponins Touted as ‘Ally’ in COVID-19 Triage

Upcoming Events

  1. Distribution 271 – Distribution Opens

    December 1

  2. Distribution 271 – Final Date for Input of Results

    December 18

  3. Distribution 271 – Report Issued (week beginning)

    December 21

View All Events

Get In Touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF
+44 (0)141 440 2888
info@ukneqas-cm.org.uk

MENU

  • My front page
  • Scheme Information
  • Register to participate
  • News
  • Contact Us
  • Privacy Policy

About UKNEQAS

Since 1969 the United Kingdom National External Quality Assessment Service (UK NEQAS) has been providing a comprehensive world-wide service that enables laboratories to fulfil quality goals and facilitate optimal patient care. UK NEQAS now comprises a network of 390 schemes operating from 26 centres based at major hospitals, research institutions and universities throughout the UK.

NHS Greater Glasgow & Clyde, operating UK NEQAS Cardiac Markers, is a UKAS accredited proficiency testing provider (No:8560)(BS EN ISO/IEC 17043:2010). We are a non-profit centre working within NHS Greater Glasgow and Clyde to improve cardiac biomarker investigations in the clinical laboratory sector for the benefit of patients.

Get in touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF
+44 (0)141 440 2888
info@ukneqas-cm.org.uk
©UKNEQAS-Cardiac Markers 2018 | Date last modified November 9, 2020 - 11:40 am